Patents
Patents for C07C 291 - Compounds containing carbon and nitrogen and having functional groups not covered by groups (1,596)
07/2003
07/03/2003US20030125489 Open chain alkoxyamine compounds and their use as polymerization regulators
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003CN1427809A Nitroaromatic solubilizer for nitroxyls in aromatic solvents
06/2003
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/03/2003US6572717 Solid propellants,
05/2003
05/21/2003EP1311555A1 Acrylate contact adhesive materials having tight molecular weight distribution
05/21/2003EP1311492A1 Method for producing lamotrigine from alpha-oxo-2,3-dichlorophenyl acetamidino-aminoguanidino hydrazone by ring closure reaction
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/08/2003WO2002076928A3 Alkylamine derivatives as antifouling agents
05/08/2003US20030087957 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
04/2003
04/29/2003CA2078028C A tramadol n-oxide material, enantiomers and compositions thereof, and their use
04/24/2003US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases
04/24/2003US20030078424 Method for oxidizing tertiary amines and aromatic heterocycles containing nitrogen
04/24/2003US20030078297 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
04/17/2003WO2003031395A1 Isocyanato-isocyano compounds
04/17/2003US20030073833 Antiinflammatory agents; anticoagulants
04/10/2003US20030069442 Novel process for the preparation of alpha-(2-4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof
04/09/2003EP1300393A1 Isocyanato-isocyano-compounds
04/02/2003EP1296931A2 Polyamine analogues as cytotoxic agents
04/02/2003EP0850231B1 Process for preparing a 2-chloro-5-chloromethyl-thiazole compound
03/2003
03/25/2003US6538141 Method for preparing nitroxides
03/25/2003US6538116 For therapy of inflammatory or painful disorder
03/06/2003US20030045755 Polyamine analogues as cytotoxic agents
03/06/2003US20030045574 Such as alpha-phenyl-N-(7-tert-butoxycarbonylamino-3,5-dimethyladamantane)nitrone for treatment of neurological/ inflammatory diorders, and aging, which result from the overproduction of nitric oxide
03/06/2003US20030044681 Battery and battery electrode
02/2003
02/18/2003US6521663 Aminoguanidinyl- and Alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors
02/11/2003US6518326 Open chain alkoxyamine compounds and their use as polymerization regulators
02/11/2003US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
02/06/2003WO2003010128A2 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids
02/05/2003CN1395559A Novel process for preparation of alpha-(2.4-disulfophenyl)-N-tert-butylnitrone and pharmaceutically acceptable salts thereof
01/2003
01/30/2003WO2003008393A1 Method for producing lamotrigine from alpha-oxo-2,3-dichlorophenyl acetamidino-aminoguanidino hydrazone by ring closure reaction
01/29/2003EP1278712A2 Nitroaromatic solubilizer for nitroxyls in aromatic solvents
01/29/2003CN1394200A Process for preparation of alpha-(2,4-disulfophenyl)-N-tert-butylnitrone and pharmaceutically acceptable salts thereof
01/28/2003US6511991 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
01/23/2003WO2003006427A1 Compounds that release nitric oxide at controlled rates upon photolysis
01/22/2003EP1276715A2 Method for oxidizing tertiary amines and aromatic heterocycles containing nitrogen
01/21/2003US6509463 Isocyanoalkylcarbonic acid derivatives, the reaction thereof in isocyanide multicomponent reactions to form sec-amido-alkylcarbonic acid derivatives, and those sec-amidoalkyl-carbonic acid derivatives
01/14/2003CA2222303C Use of at least one no synthase inhibitor for treating sensitive skin
01/02/2003EP1268406A1 Method for oximating organic carbonyl compounds and/or ch-acid compounds
12/2002
12/27/2002WO2002056874A3 Lipid-based nitric oxide donors
12/18/2002EP1265856A1 Novel process for the preparation of alpha-(2-4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof
12/17/2002US6494944 Amine oxides as asphalt emulsifiers
12/12/2002WO2002098430A1 Antimycotic agent
12/12/2002US20020188135 Amino acid derivatives and methods of making the same
12/12/2002CA2448040A1 Antimycotic agent
12/11/2002EP1263862A2 Amine oxides as asphalt emulsifiers
12/05/2002US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
11/2002
11/28/2002US20020177723 Compounds and methods for the treatment of inflammatory and immune disorders
11/21/2002WO2002078615A3 Antioxidant nitroxides and nitrones as therapeutic agents
11/19/2002CA2038934C Anti-cancer compounds
11/14/2002US20020168417 Agrochemical compositions and surfactant compounds
11/12/2002US6479697 Process for the preparation of α-(2-4-disulfophenyl)-N-tert-burtylnitrone and pharmaceutically acceptable salts thereof
11/12/2002US6479669 Peptide mimetics
10/2002
10/29/2002US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/23/2002EP1250320A1 Novel process for the preparation of alpha-(2-4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof
10/15/2002US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/10/2002WO2002078615A2 Antioxidant nitroxides and nitrones as therapeutic agents
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002CA2442798A1 Antioxidant nitroxides and nitrones as therapeutic agents
10/03/2002WO2002076928A2 Alkylamine derivatives as antifouling agents
10/03/2002US20020143011 Tri-substituted phenyl derivatives and processes for their preparation
10/03/2002CA2441197A1 Alkylamine derivatives as antifouling agents
10/02/2002EP1245558A1 Alkylamine derivates as anti-fouling agents
09/2002
09/24/2002US6455735 Reacting a tertiary or secondary amine with hydrogen peroxide in presence of a recyclable heterogeneous layered double hydroxide exchanged with one of the anions of transition metal oxides as a catalyst in a solvent
09/19/2002US20020131967 Such as melphalan and an anti-interleukin-6 receptor antibody, administering in synergistic amounts
09/18/2002EP1239949A1 New functionalized polymeric reagents
09/12/2002US20020128318 Novel process for the preparation of alpha-(2-4-disulfophenyl)-n-tert-burtylnitrone and pharmaceutically acceptable salts thereof
08/2002
08/28/2002EP0729344B1 Active substance delivery system
08/28/2002CN1089753C Process for preparing tertiary amide oxides
08/27/2002US6441032 Treating systemic lupis and multiple sclerosis
08/15/2002WO2001072685B1 Polyamine analogues as cytotoxic agents
08/13/2002US6433008 Treating parkinson*s, alzheimer*s, autoimmune and rheumatic diseases; human immunodeficiency virus (hiv) dementia, and inflammation
07/2002
07/31/2002CN1361661A Agrochemical compositions and surfactant compounds
07/25/2002WO2002056874A2 Lipid-based nitric oxide donors
07/25/2002US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
07/25/2002CA2443080A1 Lipid-based nitric oxide donors
07/23/2002US6423865 Compounds and their application as well as a method of producing liquid crystalline polymers therefrom
07/18/2002WO2001072685A3 Polyamine analogues as cytotoxic agents
07/18/2002US20020095055 Reacting a tertiary or secondary amine with hydrogen peroxide in presence of a recyclable heterogeneous layered double hydroxide exchanged with one of the anions of transition metal oxides as a catalyst in a solvent
07/16/2002US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase.
07/11/2002WO2002034705A3 C-nitroso compounds and use thereof
07/02/2002CA2124315C Nitroaniline derivatives and their use as antitumor agents
06/2002
06/27/2002WO2001092215A3 Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same
06/27/2002US20020082221 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing S-N=O, N-N=O or
06/20/2002US20020077506 For therapy of inflammatory or painful disorder
06/13/2002WO2002028825A3 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
06/12/2002EP1213280A2 A process for the preparation of amine oxides
06/11/2002US6403627 For treatment of dysfunctions and disease conditions arising from oxidative damage; phenyl n-tert-butylnitrone derivatives
06/06/2002WO2001083567A3 Nitroaromatic solubilizer for nitroxyls in aromatic solvents
06/05/2002CN1085994C Process for producikng cellulose shaped bodies and regenerated aqueous solution of tertiary amine oxide
05/2002
05/29/2002EP1209148A1 Process for the preparation of amine oxides
05/23/2002US20020061872 For oral administration or embedded or otherwise attached to medical devices for blood collection and/or treatment
05/02/2002WO2002034705A2 C-nitroso compounds and use thereof
05/02/2002EP0530338B1 Anisotropic organic compounds
05/02/2002CA2422787A1 C-nitroso compounds and use thereof
04/2002
04/24/2002EP0885184B1 Perfluoro(alkoxycycloalkane)carbonyl fluoride compositions and their use
04/18/2002US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
04/17/2002CN1082827C Process for preparing mono-long chain amine oxide surfactants
04/11/2002WO2002028825A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16